Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sugar Chain Heterogeneity in Immunotherapy Response and Efficacy Prediction of Lung Cancer

NCT06730503 is registered in ClinicalTrials.gov with Shanghai Chest Hospital as lead sponsor.

NCT NCT06730503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06730503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sugar Chain Heterogeneity in Immunotherapy Response and Efficacy Prediction of Lung Cancer
Lead sponsor
Shanghai Chest Hospital
Phase
Observational
Overall status
Recruiting
Start date
October 1, 2023
Completion date
October 31, 2028
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer